Literature DB >> 33502742

Alternative Heterologous Expression of L-Arabinose Isomerase from Enterococcus faecium DBFIQ E36 By Residual Whey Lactose Induction.

Ticiane C de Souza1, Ravena Casemiro Oliveira1, Saulo Gonçalves Santiago Bezerra2, Ricardo M Manzo3, Enrique J Mammarella3, Denise Cavalcante Hissa4, Luciana R B Gonçalves5.   

Abstract

This study reports an alternative strategy for the expression of a recombinant L-AI from Enterococcus faecium DBFIQ E36 by auto-induction using glucose and glycerol as carbon sources and residual whey lactose as inducer agent. Commercial lactose and isopropyl β-D-1-thiogalactopyranoside (IPTG) were also evaluated as inducers for comparison of enzyme expression levels. The enzymatic extracts were purified by affinity chromatography, characterized, and applied in the bioconversion of D-galactose into D-tagatose. L-AI presented a catalytic activity of 1.67 ± 0.14, 1.52 ± 0.01, and 0.7 ± 0.04 U/mL, when expressed using commercial lactose, lactose from whey, and IPTG, respectively. Higher activities could be obtained by changing the protocol of enzyme extraction and, for instance, the enzymatic extract produced with whey presented a catalytic activity of 3.8 U/mL. The specific activity of the enzyme extracts produced using lactose (commercial or residual whey) after enzyme purification was also higher when compared to the enzyme expressed with IPTG. Best results were achieved when enzyme expression was conducted using 4 g/L of residual whey lactose for 11 h. These results proved the efficacy of an alternative and economic protocol for the effective expression of a recombinant L-AI aiming its high-scale production.

Entities:  

Keywords:  Auto-induction; Cheese whey; D-Tagatose; Escherichia coli expression; L-Arabinose isomerase

Year:  2021        PMID: 33502742     DOI: 10.1007/s12033-021-00301-2

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  25 in total

Review 1.  Tagatose, the new GRAS sweetener and health product.

Authors:  Gilbert V Levin
Journal:  J Med Food       Date:  2002       Impact factor: 2.786

2.  Bioconversion of D-galactose to D-tagatose: continuous packed bed reaction with an immobilized thermostable L-arabinose isomerase and efficient purification by selective microbial degradation.

Authors:  Min Liang; Min Chen; Xinying Liu; Yafei Zhai; Xian-wei Liu; Houcheng Zhang; Min Xiao; Peng Wang
Journal:  Appl Microbiol Biotechnol       Date:  2011-10-26       Impact factor: 4.813

Review 3.  Tagatose, a new antidiabetic and obesity control drug.

Authors:  Y Lu; G V Levin; T W Donner
Journal:  Diabetes Obes Metab       Date:  2007-10-15       Impact factor: 6.577

Review 4.  Tagatose as a Potential Nutraceutical: Production, Properties, Biological Roles, and Applications.

Authors:  Sohini Roy; Jayaram Chikkerur; Sudhir Chandra Roy; Arindam Dhali; Atul Puroshtam Kolte; Manpal Sridhar; Ashis Kumar Samanta
Journal:  J Food Sci       Date:  2018-10-18       Impact factor: 3.167

5.  Dietary supplementation with d-tagatose in subjects with type 2 diabetes leads to weight loss and raises high-density lipoprotein cholesterol.

Authors:  Thomas W Donner; Laurence S Magder; Kiarash Zarbalian
Journal:  Nutr Res       Date:  2010-12       Impact factor: 3.315

6.  Biochemical Characterization of Heat-Tolerant Recombinant L-Arabinose Isomerase from Enterococcus faecium DBFIQ E36 Strain with Feasible Applications in D-Tagatose Production.

Authors:  Ricardo Martín Manzo; André Saraiva Leão Marcelo Antunes; Jocélia de Sousa Mendes; Denise Cavalcante Hissa; Luciana Rocha Barros Gonҫalves; Enrique José Mammarella
Journal:  Mol Biotechnol       Date:  2019-06       Impact factor: 2.695

Review 7.  Current studies on biological tagatose production using L-arabinose isomerase: a review and future perspective.

Authors:  Pil Kim
Journal:  Appl Microbiol Biotechnol       Date:  2004-07-10       Impact factor: 4.813

8.  Enzymatic conversion of D-galactose to D-tagatose: cloning, overexpression and characterization of L-arabinose isomerase from Pediococcus pentosaceus PC-5.

Authors:  Yan Men; Yueming Zhu; Lili Zhang; Zhenkui Kang; Ken Izumori; Yuanxia Sun; Yanhe Ma
Journal:  Microbiol Res       Date:  2013-08-12       Impact factor: 5.415

9.  Characterization of an L-arabinose isomerase from Bacillus coagulans NL01 and its application for D-tagatose production.

Authors:  Wending Mei; Lu Wang; Ying Zang; Zhaojuan Zheng; Jia Ouyang
Journal:  BMC Biotechnol       Date:  2016-06-30       Impact factor: 2.563

Review 10.  D-Tagatose Is a Promising Sweetener to Control Glycaemia: A New Functional Food.

Authors:  Marion Guerrero-Wyss; Samuel Durán Agüero; Lisse Angarita Dávila
Journal:  Biomed Res Int       Date:  2018-01-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.